Pharmaceutical Enterprise (ME:200.708) » Johns Hopkins Drug Discovery
1715
page-template,page-template-full_width,page-template-full_width-php,page,page-id-1715,page-child,parent-pageid-25,ajax_fade,page_not_loaded,,qode-theme-ver-7.7,wpb-js-composer js-comp-ver-4.12.1,vc_responsive

Pharmaceutical Enterprise (ME:200.708)

“Pharmaceutical Enterprise” is a discussion-driven and highly interactive course designed to provide students with greater insights into a range of topics related to pharmaceutical enterprise. The course consists of six modules, each of which begins with a pre-lecture discussion session proceeded by a lecture by an expert in the given subject, and post-lecture discussion session. This 3-segment format enables students to digest the topic thoroughly and gain in-depth knowledge through peer discussion and interaction with lecturers. The course is particularly suited for individuals interested in advancing their career beyond the academic sector.

 

Fall 2021
Course Director: Takashi Tsukamoto (ttsukamoto@jhmi.edu)
Location: Rangos Building Room 590
Time: 10:00 AM – 11:30 AM
Dates: Every Friday 9/3/2021-12/17/2021


  Topic Activity
9/3 Introduction Introductory Remarks by Takashi Tsukamoto
9/3 Module 1: Intellectual Properties Pre-Lecture Discussion Session
9/10 Module 1: Intellectual Properties Lecture by Guido Galvez (Johns Hopkins Technology Ventures)
9/17 Module 1: Intellectual Properties

 

Module 2: Investment Analysis

Post-Lecture Discussion Session

 

Pre-Lecture Discussion Session

9/24 Module 2: Investment Analysis Lecture by Michael Nedelcovych (Cowen)
10/1 Module 2: Investment Analysis

 

Module 3: Venture Philanthropy

Post-Lecture Discussion Session

 

Pre-Lecture Discussion Session

10/8 Module 3: Venture Philanthropy Lecture by Kara Foshay (Cystic Fibrosis Foundation)
10/15 Module 3: Venture Philanthropy

 

Module 4: Pharmaceutical Consulting

 Post-Lecture Discussion Session

 

Pre-Lecture Discussion Session

10/22 Module 4: Pharmaceutical Consulting Lecture by Katarina Sirka (Boston Consulting Group)
10/29 Module 4: Pharmaceutical Consulting

 

Module 5: The Story of Cardioxyl

Post-Lecture Discussion Session

 

Pre-Lecture Discussion Session

11/5 Module 5: The Story of Cardioxyl Lecture by John Toscano (Johns Hopkins University)
11/12 Module 5: The Story of Cardioxyl

 

Module 6: Project Management

Post-Lecture Discussion Session

 

Pre-Lecture Discussion Session

11/19 Module 6: Project Management Lecture by Lisa Wasilewski  (AstraZeneca)
12/3

Module 6: Project Management

 

Module 7: Drug Pricing

Post-Lecture Discussion Session

 

Pre-Lecture Discussion Session

12/10

12/17

Module 7: Drug Pricing

Module 7: Drug Pricing

Lecture by Ge Bai (Johns Hopkins Carey Business School)

Post-Lecture Discussion Series 


Six teams will be formed among students and each team will facilitate pre/post-lecture sessions for the assigned module. This team activity accounts for 50% of the final grade. Class participation accounts for the other 50% of the final grade. No prior knowledge in drug discovery is required. This course is recommended for students in the 2nd or subsequent years of their graduate program, postdoctoral fellows, and faculty members. Blackboard will be used to communicate with students, share course materials, make announcements, submit assignments, and post grades.

Please contact Dr. Takashi Tsukamoto (ttsukamoto@jhmi.edu) for more information.

Important information for students with disabilities: All students with disabilities who require accommodations for this course should contact Catherine L. Will, Disability Services Coordinator for Graduate Biomedical Education (cwill@jhmi.edu or 410-614-3781) at their earliest convenience to discuss their specific needs. Please note that accommodations are not retroactive.

lowgo_bottom